Key Words: NSCLC, phase I clinical trials, novel therapies

Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancers and is histologically classified into adenocarcinoma and squamous cell carcinoma, which account for 50% and 30% of NSCLC, respectively. NSCLC … ................
................

In order to avoid copyright disputes, this page is only a partial summary.